In your opinion why was the AUGUSTUS trial such a game changer?
Professor Storey describes how the AUGUSTUS trial answered two very distinct questions:
Back to all questions
- is a NOAC such as apixaban at its licensed dose for atrial fibrillation superior in terms of safety efficacy balance compared to a vitamin K antagonist such as warfarin?
- what is the risk and or benefit is of having aspirin in the combination of antithrombotic drugs.